Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

  • Unknown sort schema '{last_sort_schema}' ignored
  • The following term was not found in PubMed: C%5BAuthor%5D.
1.

Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus.

Bril F, McPhaul MJ, Caulfield MP, Castille JM, Poynard T, Soldevila-Pico C, Clark VC, Firpi-Morell RJ, Lai J, Cusi K.

J Investig Med. 2019 Feb;67(2):303-311. doi: 10.1136/jim-2018-000864. Epub 2018 Oct 10.

PMID:
30309884
2.

Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort.

Kwo P, Fried MW, Reddy KR, Soldevila-Pico C, Khemichian S, Darling J, Zamor PJ, Napoli AA, Anduze-Faris B, Brown RS Jr.

Hepatol Commun. 2018 Feb 27;2(4):354-363. doi: 10.1002/hep4.1156. eCollection 2018 Apr.

3.

Histologic Characterization of Kratom Use-Associated Liver Injury.

Riverso M, Chang M, Soldevila-Pico C, Lai J, Liu X.

Gastroenterology Res. 2018 Feb;11(1):79-82. doi: 10.14740/gr990e. Epub 2018 Feb 23.

4.

Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes.

Bril F, Kalavalapalli S, Clark VC, Lomonaco R, Soldevila-Pico C, Liu IC, Orsak B, Tio F, Cusi K.

Clin Gastroenterol Hepatol. 2018 Apr;16(4):558-566.e2. doi: 10.1016/j.cgh.2017.12.001. Epub 2017 Dec 7.

PMID:
29223443
5.

Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma.

Dhanasekaran R, Hemming AW, Zendejas I, George T, Nelson DR, Soldevila-Pico C, Firpi RJ, Morelli G, Clark V, Cabrera R.

Oncol Rep. 2013 Apr;29(4):1259-67. doi: 10.3892/or.2013.2290. Epub 2013 Feb 18.

6.

Hepatic preservation injury: severity of hepatitis C recurrence and survival after liver transplantation.

Michaels AJ, Dhanasekaran R, Foley DP, Alkhasawneh A, Dixon L, Soldevila-Pico C, Morelli G, Cabrera R, Clark VC, Firpi RJ.

Dig Dis Sci. 2013 May;58(5):1403-9. doi: 10.1007/s10620-012-2521-9. Epub 2013 Jan 10.

7.

Histopathologic resolution of adult liver transplantation adenovirus hepatitis with cidofovir and intravenous immunoglobulin: a case report.

Kerensky T, Hasan A, Schain D, Trikha G, Liu C, Rand K, Soldevila-Pico C, Gupte A.

Transplant Proc. 2013 Jan-Feb;45(1):293-6. doi: 10.1016/j.transproceed.2012.06.059. Epub 2012 Sep 19.

PMID:
23267812
8.

Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma.

Limaye AR, Clark V, Soldevila-Pico C, Morelli G, Suman A, Firpi R, Nelson DR, Cabrera R.

Hepatol Res. 2013 Jul;43(7):757-64. doi: 10.1111/hepr.12019. Epub 2012 Nov 30.

9.

CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.

Firpi RJ, Dong H, Clark VC, Soldevila-Pico C, Morelli G, Cabrera R, Norkina O, Shuster JJ, Nelson DR, Liu C.

Liver Int. 2013 Jan;33(1):72-8. doi: 10.1111/liv.12013. Epub 2012 Oct 29.

10.

The anti-viral effect of sorafenib in hepatitis C-related hepatocellular carcinoma.

Cabrera R, Limaye AR, Horne P, Mills R, Soldevila-Pico C, Clark V, Morelli G, Firpi R, Nelson DR.

Aliment Pharmacol Ther. 2013 Jan;37(1):91-7. doi: 10.1111/apt.12098. Epub 2012 Oct 24.

11.

The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma.

Cabrera R, Pannu DS, Caridi J, Firpi RJ, Soldevila-Pico C, Morelli G, Clark V, Suman A, George TJ Jr, Nelson DR.

Aliment Pharmacol Ther. 2011 Jul;34(2):205-13. doi: 10.1111/j.1365-2036.2011.04697.x. Epub 2011 May 23.

12.

Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantation.

Cabrera R, Dhanasekaran R, Caridi J, Clark V, Morelli G, Soldevila-Pico C, Magglioca J, Nelson D, Firpi RJ.

Am J Clin Oncol. 2012 Aug;35(4):345-50. doi: 10.1097/COC.0b013e31821631f6.

13.

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.

Levy C, Peter JA, Nelson DR, Keach J, Petz J, Cabrera R, Clark V, Firpi RJ, Morelli G, Soldevila-Pico C, Lindor K.

Aliment Pharmacol Ther. 2011 Jan;33(2):235-42. doi: 10.1111/j.1365-2036.2010.04512.x. Epub 2010 Nov 17.

14.

Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study.

Han SH, Reddy KR, Keeffe EB, Soldevila-Pico C, Gish R, Chung RT, Degertekin B, Lok A; NIH HBV OLT Study Group.

Clin Transplant. 2011 Mar-Apr;25(2):E152-62. doi: 10.1111/j.1399-0012.2010.01349.x. Epub 2010 Nov 16.

15.

Bacillus cereus necrotizing fasciitis in a patient with end-stage liver disease.

Hutchens A, Gupte A, McAuliffe PF, Schain D, Soldevila-Pico C, Knapik JA, Fujita S, Mozingo DW, Richards WT.

Surg Infect (Larchmt). 2010 Oct;11(5):469-74. doi: 10.1089/sur.2009.026.

PMID:
20649455
16.

Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation.

Degertekin B, Han SH, Keeffe EB, Schiff ER, Luketic VA, Brown RS Jr, Emre S, Soldevila-Pico C, Reddy KR, Ishitani MB, Tran TT, Pruett TL, Lok AS; NIH HBV-OLT Study Group.

Am J Transplant. 2010 Aug;10(8):1823-33. doi: 10.1111/j.1600-6143.2010.03046.x. Epub 2010 Mar 23.

17.

Low prevalence of HBV DNA in the liver allograft from anti-HBc-positive donors: a single-center experience.

Pan JJ, Oh SH, Soldevila-Pico C, Nelson DR, Liu C.

Clin Transplant. 2011 Jan-Feb;25(1):164-70. doi: 10.1111/j.1399-0012.2010.01211.x.

18.

Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial.

Abdelmalek MF, Sanderson SO, Angulo P, Soldevila-Pico C, Liu C, Peter J, Keach J, Cave M, Chen T, McClain CJ, Lindor KD.

Hepatology. 2009 Dec;50(6):1818-26. doi: 10.1002/hep.23239. Erratum in: Hepatology. 2010 May;51(5):1868.

PMID:
19824078
19.

The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study.

Firpi RJ, Soldevila-Pico C, Morelli GG, Cabrera R, Levy C, Clark VC, Suman A, Michaels A, Chen C, Nelson DR.

Dig Dis Sci. 2010 Jan;55(1):196-203. doi: 10.1007/s10620-009-0981-3.

PMID:
19798576
20.

The natural history of hepatitis C cirrhosis after liver transplantation.

Firpi RJ, Clark V, Soldevila-Pico C, Morelli G, Cabrera R, Levy C, Machicao VI, Chaoru C, Nelson DR.

Liver Transpl. 2009 Sep;15(9):1063-71. doi: 10.1002/lt.21784.

Supplemental Content

Loading ...
Support Center